Syntekabio to Highlight its Cutting-edge AI-driven Discovery Solutions at BioTechX
DAEJEON, REPUBLIC OF KOREA and NEW YORK, NY / ACCESSWIRE / September 6, 2024 / Syntekabio (KOSDAQ:226330), an artificial intelligence (AI) based drug development company, today announced its participation at BioTechX USA, being held September 17-18, 2024 in Philadelphia, PA. Syntekabio is the Title Sponsor for the event and will give a keynote address and in-depth talk on its AI-driven solutions, as well as host a booth."We look forward to...
Read more








